Preferences of healthcare providers in Switzerland for attributes of pediatric hexavalent vaccines: a discrete-choice experiment [0.03%]
瑞士医疗保健提供者偏好的儿科六联疫苗属性：离散选择实验
Salome Samant,Susanne Oberle,Tomas Marcek et al.
Salome Samant et al.
Objective: To understand the preferences of healthcare providers (HCPs) in Switzerland for pediatric hexavalent vaccine attributes. Methods: ...
Addressing hepatitis delta in primary care practices in the US: a narrative review [0.03%]
在美国初级医疗机构中处理乙型肝炎病毒感染：一项记叙性综述
Tatyana Kushner,Richard R Andrews
Tatyana Kushner
Objective: Infection with the hepatitis delta virus (HDV), a unique RNA virus that requires hepatitis B virus (HBV) antigens for its assembly, replication, and transmission, causes severe viral hepatitis. Compared to HBV ...
Treatment patterns and outcomes among adults with immune thrombocytopenia receiving pharmaceutical second-line therapies: a retrospective cohort study using administrative claims data [0.03%]
接受药物二线治疗的成人免疫性血小板减少症的治疗模式和结果：使用行政索赔数据的回顾性队列研究
Yi Liang,Karen Rascati,Jamie C Barner et al.
Yi Liang et al.
Objectives: To describe and compare real-world treatment patterns and clinical outcomes among individuals with immune thrombocytopenia (ITP) receiving second-line therapies (rituximab, romiplostim, or eltrombopag). ...
Evaluation of effect of brief-intensive cognitive behavior therapy on symptoms severity in relation with catastrophic cognition in patients with panic disorder: a randomized controlled trial [0.03%]
短期强化认知行为疗法对惊恐障碍患者症状严重程度与灾难化认知关系的影响评价：一项随机对照试验
Rasoul Sabri Piro,Perjan Hashim Taha
Rasoul Sabri Piro
Introduction: Due to a dearth of evidence, we examined the effectiveness of brief-intensive CBT on symptom severity and catastrophic cognition in patients with panic disorder (PD). ...
Randomized Controlled Trial
Current medical research and opinion. 2024 Apr;40(4):689-699. DOI:10.1080/03007995.2024.2328651 2024
Extemporaneous combination therapy with nebivolol/amlodipine for the treatment of hypertension: a real-world evidence study in Europe [0.03%]
欧洲的真实世界证据研究：治疗高血压的非诺贝特/氨氯地平临时联用疗法
Giovambattista Desideri,Riccardo Cipelli,Valeria Pegoraro et al.
Giovambattista Desideri et al.
Objective: The investigation of the real-world use of the extemporaneous combination of nebivolol and amlodipine (NA-EXC) in adult patients diagnosed with hypertension in Europe. ...
Real-world diagnostic landscape and incidence of pulmonary hypertension in adult congenital heart disease patients using administrative claims data in Japan [0.03%]
利用日本行政理赔数据评估成人先天性心脏疾病患者肺动脉高压的真实世界诊断现状和发病率
Tomoko Ishizu,Yasuhiro Hayashi,Natsuko Tokushige et al.
Tomoko Ishizu et al.
Background: Although pulmonary hypertension (PH) and Eisenmenger's syndrome (ES) are common complications in adult congenital heart disease (ACHD), the frequency of diagnostic tests and the incidence of PH/ES in patients ...
Real-world evidence of Pressure-Enabled Drug Delivery for trans-arterial chemoembolization and radioembolization among patients with hepatocellular carcinoma and liver metastases [0.03%]
压力驱动药物输送在肝细胞癌和肝脏转移患者动脉化疗栓塞和放射性微球栓塞中的真实世界证据
Keziah Cook,Deepshekhar Gupta,Yunjuan Liu et al.
Keziah Cook et al.
Objectives: Pressure-Enabled Drug Delivery (PEDD), a method using pressure to advance catheter-delivered drug distribution, can improve treatment for hepatocellular carcinoma (HCC) and liver metastases, but real-world evi...
Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucoma [0.03%]
开角型青光眼患者可能增加遵医行为风险的合并症流行率研究
M Francesca Cordeiro,Philippe Denis,Carlo Astarita et al.
M Francesca Cordeiro et al.
Objective: To evaluate the prevalence of comorbidities that may limit or prevent adherence to topical ocular hypotensive therapy in patients with open-angle glaucoma (OAG). ...
Model-based simulation of glycaemic effect and body weight loss when switching from semaglutide or dulaglutide to once weekly tirzepatide [0.03%]
从塞马格鲁肽或杜拉格鲁肽转换为每周一次的替瑞帕肽后，基于模型的模拟血糖效应和体重减轻的情况
Shweta Urva,Joshua A Levine,Karen Schneck et al.
Shweta Urva et al.
Objective: To evaluate the efficacy endpoints of HbA1c and body weight loss after switching from the GLP-1 receptor agonists, semaglutide or dulaglutide, to treatment with the GIP/GLP-1 receptor agonist (RA) tirzepatide. ...
Antidepressant medications have evolved in terms of speed of onset of efficacy: How can we best measure antidepressant treatment response? [0.03%]
抗抑郁药物在起效速度上已经进化：我们如何最好地测量抗抑郁治疗的反应？
Jan A Sedway,Mark G A Opler,Leslie Citrome
Jan A Sedway